A Comparison of Glyburide and Insulin in Women with Gestational Diabetes Mellitus
Top Cited Papers
Open Access
- 19 October 2000
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 343 (16) , 1134-1138
- https://doi.org/10.1056/nejm200010193431601
Abstract
Women with gestational diabetes mellitus are rarely treated with a sulfonylurea drug, because of concern about teratogenicity and neonatal hypoglycemia. There is little information about the efficacy of these drugs in this group of women.Keywords
This publication has 38 references indexed in Scilit:
- The Large FetusClinical Obstetrics and Gynecology, 1999
- Human placental glucose uptake and transport are not altered by the oral antihyperglycemic agent metforminPublished by Elsevier ,1997
- Dose-Dependent Effects of Glyburide on Insulin Secretion and Glucose Uptake in HumansDiabetes Care, 1991
- Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: A multicenter controlled trialThe Journal of Pediatrics, 1991
- Oral Hypoglycemic AgentsNew England Journal of Medicine, 1989
- Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjectsDiabetes, 1987
- Mechanism of improvement in glucose metabolism after chronic glyburide therapyDiabetes, 1984
- Metformin in management of pregnant insulin-independent diabeticsDiabetologia, 1979
- Sulphonylurea Drugs in PregnancyBMJ, 1964
- Chlorpropamide and Perinatal MortalityBMJ, 1963